Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M M Horowitz

Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis

Bone Marrow Transplantation

Transplantation

Hematology

2011

English

Attitudes of Faculty Members, Residents, Students, and Community Physicians Toward Health Promotion

English

Related publications

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

Bone Marrow Transplantation

Transplantation

Hematology

2017

English

Outcomes for Reduced-Intensity Allogeneic Transplantation for Multiple Myeloma: An Analysis of Prognostic Factors From the Chronic Leukaemia Working Party of the EBMT

English

Prognostic Factors and Outcomes of Severe Gastrointestinal GVHD After Allogeneic Hematopoietic Cell Transplantation

Bone Marrow Transplantation

Transplantation

Hematology

2014

English

Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.

English

Prognostic Factors for Mortality Among Day 100 Survivors After Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2018

English

The Influence of Early Transplantation, Age, GVHD Prevention Regimen, and Other Factors on Outcome of Allogeneic Transplantation for CML Following BuCy

Bone Marrow Transplantation

Transplantation

Hematology

2000

English

Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV

Cellular Therapy and Transplantation

Transplantation

Molecular Medicine

2017

English

Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2017

English

Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M M Horowitz

Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis

Attitudes of Faculty Members, Residents, Students, and Community Physicians Toward Health Promotion

Related publications

Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era

Outcomes for Reduced-Intensity Allogeneic Transplantation for Multiple Myeloma: An Analysis of Prognostic Factors From the Chronic Leukaemia Working Party of the EBMT

Prognostic Factors and Outcomes of Severe Gastrointestinal GVHD After Allogeneic Hematopoietic Cell Transplantation

Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.

Prognostic Factors for Mortality Among Day 100 Survivors After Allogeneic Hematopoietic Cell Transplantation

The Influence of Early Transplantation, Age, GVHD Prevention Regimen, and Other Factors on Outcome of Allogeneic Transplantation for CML Following BuCy

Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV

Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome

Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase